CNSX:QCC

Quadron Cannatech Competitors

Notice: This company has been marked as potentially delisted and may not be actively trading.

Add

Compare

Today's Range N/A

50-Day Range

$0.27

MA: $0.27▼

$0.27

52-Week Range N/A

VolumeN/A

Average Volume32,330 shs

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Quadron Cannatech (CNSX:QCC) Vs. VMD, TMD, HTL, PTQ, PHM, and HSM

Should you be buying QCC stock or one of its competitors? Companies in the industry of "medical devices" are considered alternatives and competitors to Quadron Cannatech, including Viemed Healthcare (VMD), Titan Medical Inc. (TMD.TO) (TMD), Hamilton Thorne (HTL), Protech Home Medical (PTQ), Protech Home Medical (PHM), and Helius Medical Technologies (HSM).

Quadron Cannatech vs. Viemed Healthcare Stock

Viemed Healthcare (TSE:VMD) and Quadron Cannatech (CNSX:QCC) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, risk and valuation.

Valuation & Earnings

This table compares Viemed Healthcare and Quadron Cannatech's revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Viemed Healthcare	C$121.56 million	3.97	$28.56 million	C$0.72	16.90
Quadron Cannatech	N/A	N/A	N/A	N/A	N/A

Viemed Healthcare has higher revenue and earnings than Quadron Cannatech.

Profitability

This table compares Viemed Healthcare and Quadron Cannatech's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Viemed Healthcare	N/A	N/A	N/A
Quadron Cannatech	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Viemed Healthcare and Quadron Cannatech, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Viemed Healthcare	0	1	0	0	2.00
Quadron Cannatech	0	0	0	0	N/A

Summary

Viemed Healthcare beats Quadron Cannatech on 1 of the 1 factors compared between the two stocks.

Quadron Cannatech vs. Titan Medical Inc. (TMD.TO) Stock

Titan Medical Inc. (TMD.TO) (TSE:TMD) and Quadron Cannatech (CNSX:QCC) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, risk and valuation.

Valuation & Earnings

This table compares Titan Medical Inc. (TMD.TO) and Quadron Cannatech's revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Titan Medical Inc. (TMD.TO)	C$20 million	14.73	$-39,538,525.00	C($0.36)	-7.45
Quadron Cannatech	N/A	N/A	N/A	N/A	N/A

Quadron Cannatech has lower revenue, but higher earnings than Titan Medical Inc. (TMD.TO).

Profitability

This table compares Titan Medical Inc. (TMD.TO) and Quadron Cannatech's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Titan Medical Inc. (TMD.TO)	N/A	N/A	N/A
Quadron Cannatech	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Titan Medical Inc. (TMD.TO) and Quadron Cannatech, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Titan Medical Inc. (TMD.TO)	0	0	0	0	N/A
Quadron Cannatech	0	0	0	0	N/A

Summary

Titan Medical Inc. (TMD.TO) beats Quadron Cannatech on 1 of the 1 factors compared between the two stocks.

Quadron Cannatech vs. Hamilton Thorne Stock

Hamilton Thorne (CVE:HTL) and Quadron Cannatech (CNSX:QCC) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, risk and valuation.

Valuation & Earnings

This table compares Hamilton Thorne and Quadron Cannatech's revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hamilton Thorne	C$38.36 million	6.28	$968,653.00	C$0.01	248.57
Quadron Cannatech	N/A	N/A	N/A	N/A	N/A

Hamilton Thorne has higher revenue and earnings than Quadron Cannatech.

Profitability

This table compares Hamilton Thorne and Quadron Cannatech's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Hamilton Thorne	N/A	N/A	N/A
Quadron Cannatech	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Hamilton Thorne and Quadron Cannatech, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hamilton Thorne	0	0	4	0	3.00
Quadron Cannatech	0	0	0	0	N/A

Hamilton Thorne currently has a consensus target price of C$1.82, suggesting a potential upside of 4.37%.

Summary

Hamilton Thorne beats Quadron Cannatech on 2 of the 2 factors compared between the two stocks.

Quadron Cannatech vs. Protech Home Medical Stock

Quadron Cannatech (CNSX:QCC) and Protech Home Medical (CVE:PTQ) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, profitability, dividends and risk.

Earnings & Valuation

This table compares Quadron Cannatech and Protech Home Medical's top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quadron Cannatech	N/A	N/A	N/A	N/A	N/A
Protech Home Medical	C$97.76 million	2.42	C$-8,245,376.00	C($0.07)	-28.65

Quadron Cannatech has higher earnings, but lower revenue than Protech Home Medical.

Profitability

This table compares Quadron Cannatech and Protech Home Medical's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Quadron Cannatech	N/A	N/A	N/A
Protech Home Medical	N/A	N/A	N/A

Analyst Ratings

This is a summary of current ratings for Quadron Cannatech and Protech Home Medical, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quadron Cannatech	0	0	0	0	N/A
Protech Home Medical	0	0	5	0	3.00

Protech Home Medical has a consensus price target of C$2.58, suggesting a potential upside of 21.86%.

Summary

Protech Home Medical beats Quadron Cannatech on 2 of the 2 factors compared between the two stocks.

Quadron Cannatech vs. Protech Home Medical Stock

Quadron Cannatech (CNSX:QCC) and Protech Home Medical (CVE:PHM) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, profitability, dividends and risk.

Earnings & Valuation

This table compares Quadron Cannatech and Protech Home Medical's top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quadron Cannatech	N/A	N/A	N/A	N/A	N/A
Protech Home Medical	C$77.14 million	0.62	C$833,022.00	C$0.00	57.50

Protech Home Medical has higher revenue and earnings than Quadron Cannatech.

Profitability

This table compares Quadron Cannatech and Protech Home Medical's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Quadron Cannatech	N/A	N/A	N/A
Protech Home Medical	N/A	N/A	N/A

Analyst Ratings

This is a summary of current ratings for Quadron Cannatech and Protech Home Medical, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quadron Cannatech	0	0	0	0	N/A
Protech Home Medical	0	0	0	0	N/A

Summary

Protech Home Medical beats Quadron Cannatech on 1 of the 1 factors compared between the two stocks.

Quadron Cannatech vs. Helius Medical Technologies Stock

Quadron Cannatech (CNSX:QCC) and Helius Medical Technologies (TSE:HSM) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, profitability, dividends and risk.

Earnings & Valuation

This table compares Quadron Cannatech and Helius Medical Technologies' top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quadron Cannatech	N/A	N/A	N/A	N/A	N/A
Helius Medical Technologies	C$622,000.00	65.17	C$-38,078,347.00	C($16.48)	-1.06

Quadron Cannatech has higher earnings, but lower revenue than Helius Medical Technologies.

Profitability

This table compares Quadron Cannatech and Helius Medical Technologies' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Quadron Cannatech	N/A	N/A	N/A
Helius Medical Technologies	N/A	N/A	N/A

Analyst Ratings

This is a summary of current ratings for Quadron Cannatech and Helius Medical Technologies, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quadron Cannatech	0	0	0	0	N/A
Helius Medical Technologies	0	0	0	0	N/A

Summary

Helius Medical Technologies beats Quadron Cannatech on 1 of the 1 factors compared between the two stocks.